Intravenous thrombolysis for acute stroke: current standards and future directions.

about

No space left for intravenous thrombolysis in acute stroke: CONS.

P2860

Q38381277-8F96844B-B386-41D8-87C4-EA236BB112B7

P2860

Intravenous thrombolysis for acute stroke: current standards and future directions.

Item

http://www.wikidata.org/entity/Q39028528

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Intravenous thrombolysis for acute stroke: current standards and future directions.

@en

Intravenous thrombolysis for acute stroke: current standards and future directions.

@nl

type

Item

label

Intravenous thrombolysis for acute stroke: current standards and future directions.

@en

Intravenous thrombolysis for acute stroke: current standards and future directions.

@nl

prefLabel

Intravenous thrombolysis for acute stroke: current standards and future directions.

@en

Intravenous thrombolysis for acute stroke: current standards and future directions.

@nl

P1476

Intravenous thrombolysis for acute stroke: current standards and future directions.

@en

P2093

Bharathkumar Cheripelli

http://www.w3.org/2001/XMLSchema#string

Keith W Muir

http://www.w3.org/2001/XMLSchema#string

Lucille Ramani

http://www.w3.org/2001/XMLSchema#string

Xuya Huang

http://www.w3.org/2001/XMLSchema#string

P2860

The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial

Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis

Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: a secondary analysis of the European-Australasian Acute Stroke Study (ECASS II)

Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study

A randomized trial of tenecteplase versus alteplase for acute ischemic stroke

Thrombolysis in very elderly people: controlled comparison of SITS International Stroke Thrombolysis Registry and Virtual International Stroke Trials Archive

Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke

Tissue plasminogen activator for acute ischemic stroke

Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association

A trial of imaging selection and endovascular treatment for ischemic stroke

P2888

s11936-015-0373-2

P304

373

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11936-015-0373-2

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

273702137

http://www.w3.org/2001/XMLSchema#string

P698

25778425

http://www.w3.org/2001/XMLSchema#string

P921

thrombolysis

Intravenous thrombolysis for acute stroke: current standards and future directions.

about

P2860

P2860

Intravenous thrombolysis for acute stroke: current standards and future directions.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P698

P921